KR880000095A - 케토티펜 함유 약학적 조성물 - Google Patents
케토티펜 함유 약학적 조성물 Download PDFInfo
- Publication number
- KR880000095A KR880000095A KR1019870006312A KR870006312A KR880000095A KR 880000095 A KR880000095 A KR 880000095A KR 1019870006312 A KR1019870006312 A KR 1019870006312A KR 870006312 A KR870006312 A KR 870006312A KR 880000095 A KR880000095 A KR 880000095A
- Authority
- KR
- South Korea
- Prior art keywords
- minutes
- pharmaceutical composition
- ketotifen
- fat
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1 도는 실시예 1에 대한 전형적인 방출속도를 나타내는 그래프.
제 2 도는 약품의 농도를 나타낸 그래프.
제 3 도는 실시예 1의 정제의 위약에 대한 참조의 배가된 값을 나타내는 그래프.
Claims (22)
- 일일 1회 투여형의 경구용 케토티펜 약학적 조성물.
- 제 1 항에 있어서, 2mg의 케도티펜으로 구성된 조성물.
- 플라즈마내의 케토티펜의 평균 유지시간이 투여후 24내지 28시간이며 케토티펜으로 구성된 일일 1회 투여용 약학적 조성물.
- 안정화된 상테에서의 투여에 의하여비율이 1.2내지 2.4이고 케토티펜으로 구성된 일일 1회투여용 약학적 조성물.
- 제 4 항에 있어서, 일일 2회 투여용으로 투여할 때 상대적인 Cmax가 0.5내지 1.3이고 상대적인 Cmin이 0.6내지 1.3인 약학적 조성물.
- 120분 뒤 pH가 6.8로 변하는 0.1N HCI 500㎖내에서 37℃의 120rpm으로 회선패들-방법에 의한 실험실내 케토티펜방출 속도가 다음과 같은 케토티펜으로 구성된 약학적 조성물.15분후 10-20%30분후 15-25%60분후 25-35%120분후 35-50%150분후 40-55%180분후 45-60%
- 500㎖의 증류수에서 37℃로 50rpm에 의한 회전패들 방법에 의할때 다음과 같은 실험실적 케토티펜 방출속도를 갖는 케토티팬으로 구성된 경구용 약학적 조성물.120분후 10-30%240분후 20-50%360분후 30-60%480분후 40-75%720분후 55-90%960분후 70-95%1440분후 80-100%
- 120분뒤 pH가 6.8로 변하는 0.1N의 HCI 500㎖내에서 37℃로 120rpm에 의한 회전 바스켓 방법에 의하여 다음과 같은 실험실적 케토티펜 방출속도를 갖는 케토티펜으로 구성된 경구용 약학적 조성물.15분후 5-20%30분후 10-25%60분후 15-40%120분후 25-60%180분후 35-70%240분후 40-75%300분후 45-80%
- 제 1 항 내지 제 8 항중 어느 한항에 있어서 하루 2번 투여되는 공지된 형에 비하여 상대적으로 안정한 상태의 생물학적 효능이 70내지 125%인 약학적 조성물.
- 친유성 물질내의 케토티펜을 함유하는 일일 1회 투여용 약학적 조성물.
- 제10항에 있어서, 하루 2번 투여되는 공지된 형에 비하여 상대적으로 안정한 상태의 생물학적 효능이 70내지 125%인 약학적 조성물.
- 제10항 또는 제11항에 있어서, 친유성 물질이 지방인 약학적 조성물.
- 제12항에 있어서, 지방이 글리세릴 팔리모스테아레이트인 약학적 조성물.
- 제12항에 있어서, 지방이 혼합물이 형태인 약학적 조성물.
- 제 1 항 내지 제14항의 어느 한항에 있어서, 조성물이 정제조성물인 약학적 조성물.
- 제12항 내지 제14항의 어느 한항에 있어서, 케토티펜의 지방에 대한 비율이 1 : 10내지 1 : 30인 약학적 조성물.
- 제12항 내지 제16항의 어느 한항에 있어서, 케토티펜이 지방입자인 약학적 조성물.
- 제 1 항 내지 제17항의 어느 한항에 있어서, 케토티펜이 위약입자와의 혼합물인 약학적 조성물.
- 제17항 또는 제18항에 있어서, 케토티펜이 외부 유탁액상으로 피복된 약학적 조성물.
- 케토티펜과 글리세릴 팔미토스테아레이트를 함유하는 지방입자, 전분과 폴리비닐 피롤리돈을 함유하는 락토즈 위약입자와 마그네슘 스테아레이트를 함유하는 외상으로 구성된 약학적 조성물.
- 제 1 항 내지 제20항의 어느 한항에 있어서, 비-장용 피복의 정제형인 약학적 조성물.
- 실시예중 어느 하나에 서술된 경구투여용 케토티펜의 약학적 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3620830 | 1986-06-21 | ||
DEP3620830.2 | 1986-06-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880000095A true KR880000095A (ko) | 1988-03-23 |
Family
ID=6303418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870006312A KR880000095A (ko) | 1986-06-21 | 1987-06-20 | 케토티펜 함유 약학적 조성물 |
Country Status (30)
Country | Link |
---|---|
US (1) | US5399360A (ko) |
JP (2) | JPS638332A (ko) |
KR (1) | KR880000095A (ko) |
AT (1) | AT400521B (ko) |
AU (1) | AU611637B2 (ko) |
BE (1) | BE1000661A4 (ko) |
CA (1) | CA1314227C (ko) |
CH (3) | CH676201A5 (ko) |
CY (1) | CY1589A (ko) |
DE (1) | DE3719818C2 (ko) |
DK (1) | DK314387A (ko) |
ES (1) | ES2006170A6 (ko) |
FI (1) | FI872733A (ko) |
FR (1) | FR2600253B1 (ko) |
GB (1) | GB2191696B (ko) |
GR (1) | GR870965B (ko) |
HK (1) | HK27691A (ko) |
HU (1) | HU202753B (ko) |
IE (1) | IE59178B1 (ko) |
IL (1) | IL82924A (ko) |
IT (1) | IT1216822B (ko) |
LU (1) | LU86928A1 (ko) |
MY (1) | MY101566A (ko) |
NL (1) | NL8701335A (ko) |
NO (1) | NO872551L (ko) |
NZ (1) | NZ220769A (ko) |
PH (1) | PH26313A (ko) |
PT (1) | PT85128B (ko) |
SE (1) | SE8702563L (ko) |
ZA (1) | ZA874450B (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891460A (en) * | 1995-06-07 | 1999-04-06 | University Of Southern California University Park Campus | Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof |
EP1014979A4 (en) * | 1997-06-09 | 2003-08-20 | Bridge Pharma Inc | CONNECTIONS WITH COMBINED ANTIHISTAMINIC AND FAST-CELL STABILIZING ACTIVITY FOR OPHTHALMOLOGICAL USE |
US6740889B1 (en) * | 1998-09-28 | 2004-05-25 | Applied Materials, Inc. | Charged particle beam microscope with minicolumn |
WO2001039774A1 (en) * | 1999-12-01 | 2001-06-07 | Klein Pharmaceuticals | Topical administration of ketotifen |
US20030153620A1 (en) | 2000-05-12 | 2003-08-14 | Meakin Timothy David | Treating eczema and/or psoriasis |
NZ514536A (en) * | 2001-09-28 | 2005-02-25 | Meracol Corp Ltd | Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties |
ITMI20012366A1 (it) * | 2001-11-09 | 2003-05-09 | Farmatron Ltd | Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali |
JP4867128B2 (ja) * | 2002-10-01 | 2012-02-01 | 大正製薬株式会社 | 経口鼻炎治療用組成物 |
US20070129402A1 (en) * | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
US20060160852A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
JP2008525313A (ja) * | 2004-12-27 | 2008-07-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬の安定化方法 |
US20060246003A1 (en) * | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
US20060159753A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Matrix type sustained-release preparation containing basic drug or salt thereof |
WO2008153761A1 (en) * | 2007-05-23 | 2008-12-18 | Mastcell Pharmaceuticals, Inc. | Methods |
WO2009142772A2 (en) | 2008-05-23 | 2009-11-26 | Mastcell Pharmaceuticals, Inc. | Methods and treatment for allergies and inflammation associated with gastrointestinal diseases |
EP2589378A1 (en) * | 2010-10-14 | 2013-05-08 | Deva Holding Anonim Sirketi | Coating of cetyl myristate and/or cetyl palmitate particles |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH531000A (de) * | 1970-03-11 | 1972-11-30 | Sandoz Ag | Verfahren zur Herstellung neuer Benzocycloheptathiophene |
DE2360796B2 (de) * | 1973-12-06 | 1977-06-02 | Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München | Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm |
DE2426811A1 (de) * | 1974-06-04 | 1976-01-08 | Klinge Co Chem Pharm Fab | Verfahren zur herstellung von retard-tabletten |
JPS51142543A (en) * | 1975-05-20 | 1976-12-08 | Sandoz Ag | Improvement in organic compound |
US4073915A (en) * | 1975-05-20 | 1978-02-14 | Sandoz Ltd. | Treating asthma |
FR2440371A1 (fr) * | 1978-10-31 | 1980-05-30 | Fisons Ltd | Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer |
GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
JPH0667835B2 (ja) * | 1984-03-01 | 1994-08-31 | サンド・アクチエンゲゼルシヤフト | 医薬組成物 |
DE3421468A1 (de) * | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
NL8502178A (nl) * | 1984-08-16 | 1986-03-17 | Sandoz Ag | Nieuwe farmaceutische preparaten. |
US5069911A (en) * | 1985-02-05 | 1991-12-03 | Sandoz Ltd. | Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions |
DE3505433A1 (de) * | 1985-02-16 | 1986-08-21 | Basf Ag, 6700 Ludwigshafen | Direkttablettierhilfsmittel |
FR2581541B1 (fr) * | 1985-05-09 | 1988-05-20 | Rhone Poulenc Sante | Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation |
US4797286A (en) * | 1985-11-12 | 1989-01-10 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulations |
US4798725A (en) * | 1986-06-16 | 1989-01-17 | Norwich Eaton Pharmaceuticals, Inc. | Sustained release capsule |
-
1987
- 1987-06-09 HU HU872627A patent/HU202753B/hu unknown
- 1987-06-09 NL NL8701335A patent/NL8701335A/nl not_active Application Discontinuation
- 1987-06-13 DE DE3719818A patent/DE3719818C2/de not_active Expired - Lifetime
- 1987-06-15 MY MYPI87000814A patent/MY101566A/en unknown
- 1987-06-16 CH CH1925/89A patent/CH676201A5/de not_active IP Right Cessation
- 1987-06-16 CH CH2267/87A patent/CH672735A5/de not_active IP Right Cessation
- 1987-06-17 GB GB8714131A patent/GB2191696B/en not_active Expired - Lifetime
- 1987-06-17 ES ES8701784A patent/ES2006170A6/es not_active Expired
- 1987-06-18 BE BE8700679A patent/BE1000661A4/fr not_active IP Right Cessation
- 1987-06-18 FR FR878708505A patent/FR2600253B1/fr not_active Expired - Lifetime
- 1987-06-18 FI FI872733A patent/FI872733A/fi not_active Application Discontinuation
- 1987-06-18 SE SE8702563A patent/SE8702563L/xx not_active Application Discontinuation
- 1987-06-18 NO NO872551A patent/NO872551L/no unknown
- 1987-06-19 IE IE163487A patent/IE59178B1/en not_active IP Right Cessation
- 1987-06-19 CA CA000540178A patent/CA1314227C/en not_active Expired - Lifetime
- 1987-06-19 IT IT8748075A patent/IT1216822B/it active
- 1987-06-19 PH PH35433A patent/PH26313A/en unknown
- 1987-06-19 DK DK314387A patent/DK314387A/da not_active Application Discontinuation
- 1987-06-19 ZA ZA874450A patent/ZA874450B/xx unknown
- 1987-06-19 GR GR870965A patent/GR870965B/el unknown
- 1987-06-19 NZ NZ220769A patent/NZ220769A/en unknown
- 1987-06-19 LU LU86928A patent/LU86928A1/fr unknown
- 1987-06-19 PT PT85128A patent/PT85128B/pt unknown
- 1987-06-19 IL IL82924A patent/IL82924A/xx not_active IP Right Cessation
- 1987-06-19 AT AT0156187A patent/AT400521B/de not_active IP Right Cessation
- 1987-06-19 AU AU74525/87A patent/AU611637B2/en not_active Ceased
- 1987-06-20 JP JP62154265A patent/JPS638332A/ja active Pending
- 1987-06-20 KR KR1019870006312A patent/KR880000095A/ko not_active Application Discontinuation
-
1989
- 1989-06-16 CH CH1924/89A patent/CH674805A5/de not_active IP Right Cessation
-
1991
- 1991-04-11 HK HK276/91A patent/HK27691A/xx not_active IP Right Cessation
-
1992
- 1992-04-03 CY CY1589A patent/CY1589A/xx unknown
- 1992-09-07 JP JP4238166A patent/JP2860013B2/ja not_active Expired - Lifetime
-
1993
- 1993-08-11 US US08/105,532 patent/US5399360A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880000095A (ko) | 케토티펜 함유 약학적 조성물 | |
RU2140266C1 (ru) | Фармацевтическая композиция с регулируемым выделением на основе одной или нескольких фармацевтически приемлемых солей гамма-гидроксимасляной кислоты и способ ее получения | |
ATE462417T1 (de) | Microemulsionen als feste dosisformen zur oralen verabreichung | |
RU93051780A (ru) | Композиции с контролируемым высвобождением, содержащие оксикодон, способ снижения ежедневных доз препаратов, содержащих оксикодон | |
KR850000975A (ko) | 발프로익산과 그 염의 혼합물을 토대로 한 조성물 | |
BR9908488A (pt) | Composição farmacêutica de topiramato | |
KR920702216A (ko) | 아세틸 d-카르니틴의 녹내장 치료에의 용도 | |
KR910007516A (ko) | 서방성 활성 화합물을 함유한 압착물 | |
JPS6354319A (ja) | 放出制御カルビド−パ/レボド−パ配合剤 | |
KR940018089A (ko) | 내부조직의 방사선 손상에 대한 예방 및 처치방법 | |
EP0830129A1 (fr) | Compositions solides contenant du polyethyleneoxyde et un principe actif non amorphe | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
RU2002119210A (ru) | Суспензия, содержащая окскарбазепин | |
JPH0436243A (ja) | 催眠・鎮静剤 | |
KR890004705A (ko) | 항바이러스성 제제 | |
KR890001548A (ko) | 케토티펜 함유 약학적 조성물 | |
KR940013503A (ko) | 동맥경화증의 예방 또는 치료용 약제학적 조성물 | |
US5026706A (en) | Method for treating dysuria using naftopidil | |
KR960700701A (ko) | 파라세타몰 및 l-시스테인 또는 이것의 전구물질을 함유하는 약제조성물(pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof) | |
JPH045231A (ja) | 慢性痛用鎮痛剤 | |
IL25120A (en) | Pharmaceutical preparations containing fractions of avocado oil and / or soybean oil which cannot be sponged | |
GR3003988T3 (ko) | ||
DE60112584D1 (de) | Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit | |
HUP9900521A2 (hu) | Eljárás nagyon kis dózisú hatóanyagok szilárd dózisformáinak előállítására | |
US3689643A (en) | Combination of l-dopa, 2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinson{40 s disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |